Quetiapine Augmentation In Treatment-Resistant Depression – An Open Pilot Study

Update Il y a 4 ans
Reference: EUCTR2005-003251-13

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

To determine the efficacy of quetiapine in the treatment of depression at 8 weeks, assessed by calculation of the proportion of subjects responding by week 8, derived from the change in Montgomery Asberg Depression Rating Scale (MADRS) score from baseline to week 8.


Inclusion criteria

  • depression

Links